echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The National Health Commission Medical Administration and Hospital Administration issued the "Long-term Prescription Management Standards"

    The National Health Commission Medical Administration and Hospital Administration issued the "Long-term Prescription Management Standards"

    • Last Update: 2021-07-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


















    Article 11 Medical institutions shall provide long-term prescription services to eligible patients in accordance with the long-term prescription applicable disease types and the long-term prescription drug list formulated by the health administrative department
    .


    Article 12 When issuing long-term prescriptions, medical institutions shall give priority to the selection of national essential drugs.
    The state organizes centralized procurement and use of drugs and drugs in the national medical insurance catalogue
    .


    Article 13 Primary medical and health institutions shall strengthen the provision of drugs in the long-term prescription drug catalog to ensure that patients' long-term medication is accessible and stable
    .


    Article 14 For patients who apply for long-term prescriptions, doctors must conduct medical examinations in person and make judgments on whether they meet the conditions for long-term prescriptions
    .


    During the diagnosis and treatment activities, doctors can proactively propose long-term prescription recommendations to eligible patients
    .


    Article 15 Physicians should explain to patients the precautions for using long-term prescriptions, and they should voluntarily choose whether to use them; for patients who do not meet the conditions, they should explain the reasons to the patients
    .


    Article 16 Before issuing a long-term prescription for the first time, the physician shall conduct a comprehensive assessment of the patient’s past history, current medical history, medication regimen, compliance, disease control, etc.
    , and formulate the prescription when it is determined that the current medication regimen is safe, effective, and stable.
    Long-term prescriptions can be prescribed for patients
    .
    When a long-term prescription is issued for the first time, relevant information should be recorded in detail in the patient's medical record
    .


    Article 17: In principle, the first long-term prescription should be issued by a doctor with a qualification of an intermediate or higher professional and technical post in a disease-related professional in a medical institution above the second level, or a doctor with a professional qualification of an intermediate or higher professional and technical post in a primary medical and health institution.
    Issued
    .
    When a long-term prescription is issued again, it should be issued by a doctor from a disease-related professional in a medical institution above the second level, or a doctor from a primary medical and health institution
    .
    Encourage patients to sign long-term prescriptions with family doctors through primary medical and health institutions
    .


    For remote areas or areas where conditions are not available, the requirements may be appropriately relaxed, and the specific requirements shall be separately formulated by the provincial health administrative department based on the actual situation
    .


    Article 18 Physicians should evaluate patients based on the long-term prescription information and health files issued for the first time in the patient's medical record information
    .
    After evaluation, if the patient's condition is stable and the long-term medication management goal is reached, the long-term prescription can be issued again; if the condition is not met, the long-term prescription shall be terminated
    .
    If the long-term prescription is used again after stopping, it shall be managed according to the long-term prescription issued for the first time
    .


    Article 19 In the following situations, it is necessary to reassess the patient's condition and determine whether to terminate the long-term prescription:


    (1) The patient's long-term medication management has not reached the expected goal;


    (2) Suffering from other diseases requires other medication;


    (3) The patient is hospitalized for any reason;


    (4) Other situations where the long-term prescription needs to be terminated
    .


    Article 20 The primary medical and health institutions that issue long-term prescriptions and the higher-level hospitals must do a good job of linking up, and establish a patient prescription information sharing and circulation mechanism through informatization methods
    .


    Article 21 The form and content of long-term prescriptions shall comply with the requirements of ordinary prescription management in the "Prescription Management Measures"
    .


    Article 22 After a doctor has issued a long-term prescription, the patient may choose to dispense and take medicine at a medical institution or social retail pharmacy
    .


    Article 23 Pharmacists review long-term prescriptions, provide medication guidance and medication education to patients, and distribute medication education materials
    .
    If the primary medical and health institutions do not have the conditions, the pharmacists of the higher-level hospitals in the medical consortium shall remotely conduct prescription review or provide medication guidance services through the Internet
    .


    Article 24 When pharmacists review long-term prescriptions, provide consulting services, or dispense drugs, if they discover drug treatment-related problems or patients have potential drug safety risks, and need to carry out long-term prescription adjustments, drug reorganizations and other interventions, they should immediately contact the physicians Communicate for processing
    .


    Article 25 In principle, long-term prescription drugs shall be collected by the patient himself
    .
    Under special circumstances, due to inconvenience and other reasons, personnel who are familiar with the basic situation of the patient can pick up the card on behalf of the person and the patient with a valid ID card
    .


    Article 26 Primary medical and health institutions shall include the long-term prescription information issued by the institution in the patient's health file, and record the patient's diagnosis and treatment and medication records in detail
    .
    The family doctor team should conduct regular follow-up management of patients, evaluate changes in the patient's condition, medication compliance, and adverse drug reactions, and adjust or terminate long-term prescriptions if necessary
    .


    Article 27 Medical institutions shall establish safe medication monitoring and reporting systems
    .
    After a serious adverse drug event occurs, the patient should be actively treated, immediately reported to the medical and pharmaceutical departments, and observed and recorded
    .
    Report adverse drug reactions and other information to relevant departments in accordance with relevant regulations
    .


    Article 28 Medical institutions shall strengthen medication education for patients who use long-term prescriptions, increase their knowledge of rational medication, improve self-administration of medications and medication compliance, and inform patients that they should see a doctor promptly if they experience any discomfort during medication
    .


    Article 29 Medical institutions shall instruct patients who use long-term prescriptions to self-monitor and keep records of drug treatment effect indicators
    .
    Encourage the use of wearable devices to improve the informatization level of drug treatment effect indicator monitoring
    .
    On the premise of ensuring the safety of data and privacy, it is possible to explore the use of remote monitoring equipment connected to the Internet to carry out monitoring
    .


    Article 30 Medical institutions shall instruct patients who use long-term prescriptions, preserve medicines as required, and ensure the quality of medicines
    .


    Article 31 Medical institutions shall incorporate the diagnosis and treatment of patients with long-term prescriptions into the overall arrangements for medical management, strictly implement the requirements of relevant disease diagnosis and treatment regulations, strengthen quality control and management, and ensure medical quality and medical safety
    .


    Area to encourage qualified Article 32 and so on through the creation of micro-channel public number, clients and other patient, long-term prescription to facilitate patient query information, drug dosage, precautions
    .
    Explore the development of medication reminder, follow-up, medication consultation and other services for patients with long-term prescriptions
    .


    Article 33 The local administrative department of health and health shall formulate and implement detailed rules for the management of long-term prescriptions within its jurisdiction
    .


    Article 34 Primary medical and health institutions refer to township health centers, community health service centers (stations), village clinics, medical offices, outpatient departments, and clinics
    .


    Article 35 This specification shall come into force on the date of issuance
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.